Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Azam Azimi, Susan Tahmasebi, Keivan Moradi, Parham Nejati & Reza Alibakhshi. (2020) Severe α-Thalassemia Due to Compound Heterozygosity for Hb Adana (α59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family. Hemoglobin 44:2, pages 139-142.
Read now
Read now
Stamatia Theodoridou, Aikaterini Teli, Eleni Yfanti, Timoleon-Achilleas Vyzantiadis, Theodoros Theodoridis & Marina Economou. (2018) Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the –α3.7/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling. Hemoglobin 42:2, pages 129-131.
Read now
Read now
Tekin Aksu, Neşe Yaralı, Cengiz Bayram, Ali Fettah, Zekai Avcı & Bahattin Tunç. (2014) Homozygosity for HBA1: c.179G > A: Hb Adana in an Infant. Hemoglobin 38:6, pages 449-450.
Read now
Read now
Dewi Megawati, Ita M. Nainggolan, Maria Swastika, Susi Susanah, Johanes C. Mose, Alida R. Harahap & Iswari Setianingsih. (2014) Severe α-Thalassemia Intermedia Due to a Compound Heterozygosity for the Highly Unstable Hb Adana (HBA2: c.179G>A) and a Novel Codon 24 (HBA2: c.75T>A) Mutation. Hemoglobin 38:2, pages 149-151.
Read now
Read now
Articles from other publishers (8)
Yusuf DÖĞÜŞ, Petek ÇÜRÜK & Akif ÇÜRÜK. (2023) Is genetic counseling important in hemoglobin H disease?Hemoglobin H hastalığında genetik danışmanlık önemli midir?. Cukurova Medical Journal 48:2, pages 723-727.
Crossref
Crossref
Ashutosh Lal & Elliott Vichinsky. (2023) The Clinical Phenotypes of Alpha Thalassemia. Hematology/Oncology Clinics of North America 37:2, pages 327-339.
Crossref
Crossref
Nailil Husna & Niken Satuti Nur Handayani. (2021) Molecular and Haematological Characteristics of alpha-Thalassemia Deletions in Yogyakarta Special Region, Indonesia. Reports of Biochemistry and Molecular Biology 10:3, pages 346-353.
Crossref
Crossref
Ibrahim Kalle Kwaifa, Mei I. Lai & Sabariah Md Noor. (2020) Non-deletional alpha thalassaemia: a review. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Sharon A. Singh, Susmita Sarangi, Abena Appiah-Kubi, Peihong Hsu, W. Byron Smith, Patrick G. Gallagher, Bertil Glader & David H. K. Chui. (2018) Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlation. Pediatric Blood & Cancer 65:9, pages e27220.
Crossref
Crossref
Giovanna Cardiero, Clelia Scarano, Gennaro Musollino, Francesca Di Noce, Romeo Prezioso, Sabrina Dembech, Gaetana La Porta, Mercedes Caldora, Maria Grazia Bisconte, Rosario Colella Bisogno & Giuseppina Lacerra. (2017) Role of nonsense-mediated decay and nonsense-associated altered splicing in the mRNA pattern of two new α-thalassemia mutants. The International Journal of Biochemistry & Cell Biology 91, pages 212-222.
Crossref
Crossref
Jin Ai Mary Anne Tan, Siew Leng Kho, Chin Fang Ngim, Kek Heng Chua, Ai Sim Goh, Seoh Leng Yeoh & Elizabeth George. (2016) DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia. Scientific Reports 6:1.
Crossref
Crossref
Alida Harahap, Dewi Megawati, Ita M. Nainggolan, Maria Swastika & Iswari Setianingsih. (2015) THE ROLE OF COMPLETE BLOOD COUNT IN THE DIAGNOSIS OF HEMOGLOBIN E IN PSEUDO HIGH LEVEL OF HEMOGLOBIN A2. Open Journal of Hematology 6, pages 1.
Crossref
Crossref